The Propel a Cure organization is pleased and hopeful to be sponsoring the following research.
Propel a Cure is especially excited to be supporting the eminent immunologist, Dr. Mark Davis and his team at Stanford University. If successful, his work will be a game changer!
Research Goal: Identification of circulating and tissue-resident CD4+ T cells specific for disease-driving antigens in Crohn’s disease
Propel a Cure has prioritized the funding of a study that would lead to the identification of circulating and tissue-residant CD4+ T cells specific for disease-driving antigens in Crohn’s disease. T cells are a type of white blood cell that appear to have a major role in the body’s overactive inflammatory response that is seen in Crohn’s.